Showing results (1-10 of 657) with videos related to
Sort By:
Pageof 66
Breast Cancer Research and Treatment|October 19, 2022
Comprehensive analysis of clinicopathologic features and p53 mutation in neuroendocrine neoplasms of the breast: experience from a large academic centerSaba Shafi, Yan Hu, Anil V Parwani, et al.The American Journal of Surgical Pathology|December 16, 2022
Wnt Family Member 9b (Wnt9b) Is a Sensitive and Specific Marker for Triple-negative Breast Carcinoma Including Metaplastic CarcinomaNada Shaker, Saba Shafi, Bryce Parkinson, et al.Cancer Cytopathology|May 17, 2023
SOX17 is a highly sensitive and specific marker for metastatic ovarian and endometrial carcinomas in cytology cell block specimensSwati Satturwar, Nada Shaker, William Sinclair, et al.Human Pathology|May 27, 2022
PD-L1 (SP142 and 22C3) immunohistochemistry in clinical metastatic triple-negative or low hormone receptor breast carcinomas: experience from a large academic institutionSaba Shafi, Anil V Parwani, Zaibo LiAdvances in Anatomic Pathology|April 28, 2026
Advances in Digital Cytopathology and Artificial Intelligence ApplicationsSwati Satturwar, Anil V Parwani, Zaibo LiDiagnostic Pathology|February 22, 2024
Artificial intelligence's impact on breast cancer pathology: a literature reviewAmr Soliman, Zaibo Li, Anil V ParwaniArchives of Pathology & Laboratory Medicine|February 17, 2023
Applications of Artificial Intelligence in Breast PathologyYueping Liu, Dandan Han, Anil V Parwani, et al.Human Pathology|January 12, 2019
PD-L1 and CD8 are associated with deficient mismatch repair status in triple-negative and HER2-positive breast cancersYanjun Hou, Hiroaki Nitta, Anil V Parwani, et al.Histopathology|September 5, 2024
Identifying mesonephric-like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistryMaryam Tahir, Deyin Xing, Qingqing Ding, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Identifying SOX17 as a Sensitive and Specific Marker for Ovarian and Endometrial CarcinomasNada Shaker, Wei Chen, William Sinclair, et al.Pageof 66